Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pyridorin granted fast track status for diabetic nephropathy

July 24, 2002

Novel SGLT2 inhibitors in early development at Kissei

July 24, 2002

Zonagen awarded SBIR grant for Progenta

July 23, 2002

Aranesp approved for chemotherapy-induced anemia

July 23, 2002

Ragaglitazar development suspended

July 23, 2002

Karo Bio presents liver-selective glucocorticoid antagonists

July 23, 2002

Orexin antagonists and their use in obesity and other disorders discussed in recent patent

July 23, 2002

SomatoKine granted orphan drug status in GH insensitivity syndrome

July 22, 2002

New lanosterol synthase inhibitors under study at Roche

July 22, 2002

Pfizer identifies carbazole NPY Y5 antagonists

July 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...